Xiang HY, Xiang XY, Ten TB, Ding X, Liu YW, Luo CH. Clinical value of chemiluminescence method for detection of antinuclear antibody profiles. World J Clin Cases 2023; 11(28): 6688-6697 [PMID: 37901001 DOI: 10.12998/wjcc.v11.i28.6688]
Corresponding Author of This Article
Chun-Hua Luo, MD, Attending Doctor, Medical Laboratory Science, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, No. 183 Yiling Avenue, Yichang 443003, Hubei Province, China. douxia833@126.com
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Oct 6, 2023; 11(28): 6688-6697 Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6688
Table 1 Baseline clinical profiles of enrolled individuals
Disease
n
Sex (male/female)
Age (yr)
Systemic lupus erythematosus
138
8/130
11-77
Sicca syndrome
48
2/46
18-83
Rheumatoid arthritis
50
14/36
20-85
Scleroderma
12
3/9
38-69
Dermatomyositis
22
7/15
9-78
Healthy controls
130
31/99
14-79
Table 2 Detection rate of antinuclear antibody spectrum, n (%)
Items
Chemiluminescence method
Immunochemistry
χ2
P value
SLE
SS
Other
Total
SLE
SS
Other
Total
Anti-double-stranded DNA (dsDNA) antibody
69 (50.00)
5 (10.42)
3 (3.57)
77 (28.52)
61 (44.20)
4 (8.33)
3 (3.57)
68 (25.19)
0.764
0.382
Anti-histone (Histone) antibody
32 (23.19)
4 (8.33)
5 (5.95)
41 (15.19)
35 (25.36)
4 (8.33)
7 (8.33)
46 (17.04)
0.343
0.558
Anti-nucleosome (Nuc) antibody
40 (28.99)
1 (2.08)
4 (4.76)
45 (16.67)
36 (26.09)
1 (2.08)
3 (3.57)
40 (14.81)
0.349
0.555
Anti-Smith (Sm) antibody
18 (13.04)
1 (2.08)
2 (2.38)
21 (7.78)
17 (12.32)
0 (0.00)
1 (1.19)
18 (6.67)
0.249
0.618
Anti-ribosomal P protein (Rib-P) antibody
38 (27.54)
2 (4.17)
0 (0.00)
40 (14.81)
49 (35.51)
2 (4.17)
0 (0.00)
51 (18.89)
1.599
0.206
Anti-sicca syndrome A (Ro60) antibody
82 (59.42)
40 (83.33)
14 (16.67)
136 (50.37)
85 (61.59)
36 (75.00)
13 (15.48)
134 (49.62)
0.030
0.863
Anti-sicca syndrome A (Ro52) antibody
77 (55.80)
37 (77.08)
19 (23.46)
133 (49.26)
79 (57.25)
36 (75.00)
21 (25.00)
136 (50.37)
0.067
0.796
Anti- sicca syndrome (SSB) antibody
19 (13.77)
18 (37.50)
12 (14.29)
49 (18.15)
20 (14.49)
19 (39.58)
11 (13.10)
50 (18.52)
0.012
0.911
Anti-centromere protein B (Cenp-B) antibody
11 (7.97)
4 (8.33)
2 (2.38)
17 (6.30)
8 (5.80)
3 (6.25)
2 (2.38)
13 (4.81)
0.565
0.452
Anti-DNA topoisomerase 1 (Scl-70) antibody
5 (3.62)
0 (0.00)
6 (7.14)
11 (4.07)
4 (2.90)
0 (0.00)
6 (7.14)
10 (3.70)
0.050
0.824
Anti-histidyl tRNA synthetase (Jo-1) antibody
0 (0.00)
0 (0.00)
1 (1.19)
1 (0.37)
1 (0.72)
0 (0.00)
1 (4.62)
2 (0.74)
0.335
0.563
Anti-mitochondrial M2 (AMA-M2) antibody
2 (1.45)
1 (2.08)
3 (3.57)
6 (2.22)
2 (1.45)
0 (0.00)
3 (3.57)
5 (1.85)
0.093
0.761
Table 3 Agreement rate of antinuclear antibody spectrum (%)
Items
Positive agreement rate
Negative agreement rate
Total agreement rate
Kappa
P value
Anti-double-stranded DNA (dsDNA) antibody
89.71
92.08
91.48
0.783
< 0.05
Anti-histone (Histone) antibody
82.61
98.66
95.93
0.849
< 0.05
Anti-nucleosome (Nuc) antibody
90.00
96.09
95.19
0.819
< 0.05
Anti-Smith (Sm) antibody
83.33
97.62
96.67
0.751
< 0.05
Anti-ribosomal P protein (Rib-P) antibody
64.71
96.80
90.74
0.671
< 0.05
Anti-sicca syndrome A (Ro60) antibody
93.28
91.91
92.59
0.852
< 0.05
Anti-sicca syndrome A (Ro52) antibody
91.18
92.59
92.22
0.844
< 0.05
Anti- sicca syndrome (SSB) antibody
88.00
97.73
95.93
0.864
< 0.05
Anti-centromere protein B (Cenp-B) antibody
92.31
98.05
97.78
0.788
< 0.05
Anti-DNA topoisomerase 1 (Scl-70) antibody
80.00
98.85
98.15
0.752
< 0.05
Anti-histidyl tRNA synthetase (Jo-1) antibody
50.00
100.00
99.63
0.665
< 0.05
Anti-mitochondrial M2 (AMA-M2) antibody
80.00
99.25
98.89
0.722
< 0.05
Table 4 Diagnostic performance of antibodies detected by chemiluminescence assay and line immunoassay for systemic lupus erythematosus
Antibodies
Chemiluminescence method
Line immunoassay
AUC
95%CI
AUC
95%CI
Anti-double-stranded DNA (dsDNA) antibody
0.935
0.907-0.962
0.905
0.871-0.940
Anti-histone (Histone) antibody
0.508
0.436-0.580
0.513
0.441-0.585
Anti-nucleosome (Nuc) antibody
0.837
0.788-0.886
0.829
0.780-0.879
Anti-Smith (Sm) antibody
0.941
0.914-0.968
0.907
0.872-0.943
Anti-ribosomal P protein (Rib-P) antibody
0.776
0.721-0.831
0.791
0.738-0.844
Anti-sicca syndrome A (Ro60) antibody
0.953
0.931-0.975
0.945
0.921-0.969
Anti-sicca syndrome A (Ro52) antibody
0.946
0.920-0.972
0.929
0.900-0.958
Anti- sicca syndrome (SSB) antibody
0.650
0.584-0.716
0.661
0.596-0.727
Anti-centromere protein B (Cenp-B) antibody
0.811
0.761-0.861
0.787
0.733-0.841
Anti-DNA topoisomerase 1 (Scl-70) antibody
0.783
0.727-0.838
0.740
0.681-0.800
Anti-histidyl tRNA synthetase (Jo-1) antibody
0.821
0.769-0.874
0.781
0.722-0.841
Anti-mitochondrial M2 (AMA-M2) antibody
0.895
0.844-0.947
0.920
0.883-0.957
Citation: Xiang HY, Xiang XY, Ten TB, Ding X, Liu YW, Luo CH. Clinical value of chemiluminescence method for detection of antinuclear antibody profiles. World J Clin Cases 2023; 11(28): 6688-6697